{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:46:41Z","timestamp":1771472801223,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare","award":["HI22C0610"],"award-info":[{"award-number":["HI22C0610"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immunoglobulin G4 (IgG4)-related effusive constrictive pericarditis (ECP) is a rare manifestation of IgG4-related disease (IgG4-RD). It can lead to persistent pericardial fibrosis, resulting in cardiac tamponade, diastolic dysfunction, and heart failure. Glucocorticoids are the primary treatment for effectively reducing inflammation and preventing fibrosis. However, guidelines for monitoring treatment response are lacking and tapering glucocorticoid therapy for specific target organs remains a challenge. Recent studies on IgG4-RD have demonstrated that semiquantitative measurements of fluorine-18 fluorodeoxyglucose (<jats:sup>18<\/jats:sup>F-FDG) uptake in the main involved organs in positron emission tomography\/computed tomography (PET\/CT) scanning are correlated to disease activity. We present a case of IgG4-related ECP to demonstrate the usefulness of <jats:sup>18<\/jats:sup>F-FDG PET\/CT for diagnosing and treatment follow-up of IgG4-related ECP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Herein, a 66-year-old woman diagnosed with IgG4-related ECP presented with breathlessness, leg swelling, rales, and fever. Laboratory tests revealed markedly elevated levels of C-reactive protein, and transthoracic echocardiography revealed constrictive physiology with effusion. High IgG4 levels suggested an immune-related pathogenesis, while viral and malignant causes were excluded. Subsequent pericardial biopsy revealed lymphocyte and plasma cell infiltration in the pericardium, confirming the diagnosis of IgG4-related ECP. <jats:sup>18<\/jats:sup>F-FDG PET\/CT revealed increased uptake of <jats:sup>18<\/jats:sup>F-FDG in the pericardium, indicating isolated cardiac involvement of IgG4-RD. Treatment with prednisolone and colchicine led to a rapid improvement in the patient\u2019s condition within a few weeks. Follow-up imaging with <jats:sup>18<\/jats:sup>F-FDG PET\/CT after 3 months revealed reduced inflammation and improved constrictive physiology on echocardiography, leading to successful tapering of the prednisolone dose and discontinuation of colchicine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The rarity of IgG4-related ECP and possibility of multiorgan involvement in IgG4-RD necessitates a comprehensive diagnostic approach and personalized management. This case report highlights the usefulness of <jats:sup>18<\/jats:sup>F-FDG PET\/CT in the diagnosis and treatment follow-up of isolated pericardial involvement in IgG4-RD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03797-z","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T13:02:33Z","timestamp":1708606953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Semiquantitative 18F-FDG PET\/CT in monitoring glucocorticoid response of immunoglobulin G4-related effusive constrictive pericarditis: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Soo Yeon","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-4343","authenticated-orcid":false,"given":"Byung Joo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"3797_CR1","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94:e680.","journal-title":"Medicine"},{"key":"3797_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10741-012-9308-0","volume":"18","author":"FF Syed","year":"2013","unstructured":"Syed FF, Ntsekhe M, Mayosi BM, Oh JK. Effusive-constrictive pericarditis. Heart Fail Rev. 2013;18:277\u201387.","journal-title":"Heart Fail Rev"},{"key":"3797_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1536\/ihj.13-321","volume":"55","author":"M Tajima","year":"2014","unstructured":"Tajima M, Nagai R, Hiroi Y. IgG4-related cardiovascular disorders. Int Heart J. 2014;55:287\u201395.","journal-title":"Int Heart J"},{"key":"3797_CR4","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688\u201399.","journal-title":"Arthritis Rheumatol"},{"key":"3797_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s12149-022-01749-1","volume":"36","author":"Z Bai","year":"2022","unstructured":"Bai Z, Zhou T, Yu Z, Chen Y, Dong L. Clinical value of 18F-FDG PET\/CT in IgG4-related disease. Ann Nucl Med. 2022;36:651\u201360.","journal-title":"Ann Nucl Med"},{"key":"3797_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12872-022-02468-1","volume":"22","author":"S Malt\u00eas","year":"2022","unstructured":"Malt\u00eas S, Cabral M, Freitas P, Albuquerque C, Fernandes C, Moura D, et al. Immunoglobulin G4-related constrictive pericarditis and the importance of a thorough workup: a case report. BMC Cardiovasc Disord. 2022;22:28. https:\/\/doi.org\/10.1186\/s12872-022-02468-1.","journal-title":"BMC Cardiovasc Disord"},{"key":"3797_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","volume":"31","author":"H Umehara","year":"2021","unstructured":"Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31:529\u201333.","journal-title":"Mod Rheumatol"},{"key":"3797_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13139-017-0494-5","volume":"52","author":"HL Huang","year":"2018","unstructured":"Huang HL, Fong W, Peh WM, Niraj KA, Lam WW. The utility of FDG PET\/CT in IgG4-related disease with a focus on coronary artery involvement. Nucl Med Mol Imaging. 2018;52:53\u201361.","journal-title":"Nucl Med Mol Imaging"},{"key":"3797_CR9","doi-asserted-by":"publisher","first-page":"20210105","DOI":"10.1259\/bjr.20210105","volume":"94","author":"CYL Tang","year":"2021","unstructured":"Tang CYL, Chua WM, Cheng LTJ, Fong W, Zaheer S, Lam WWC. 18F-FDG PET\/CT manifestations of IgG4-related disease. Br J Radiol. 2021;94:20210105.","journal-title":"Br J Radiol"},{"key":"3797_CR10","first-page":"119","volume":"34","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, Wang Y, Guan Z, Jin J, Huang F, Zhu J. Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases. Clin Exp Rheumatol. 2016;34:119\u201325.","journal-title":"Clin Exp Rheumatol"},{"key":"3797_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jbspin.2014.01.010","volume":"81","author":"H Takahashi","year":"2014","unstructured":"Takahashi H, Yamashita H, Morooka M, Kubota K, Takahashi Y, Kaneko H, et al. The utility of FDG-PET\/CT and other imaging techniques in the evaluation of IgG4-related disease. Joint Bone Spine. 2014;81:331\u20136.","journal-title":"Joint Bone Spine"},{"key":"3797_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/MNM.0000000000001566","volume":"43","author":"F Dondi","year":"2022","unstructured":"Dondi F, Albano D, Bellini P, Volpi G, Giubbini R, Bertagna F. 18F-fluorodeoxyglucose PET and PET\/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review. Nucl Med Commun. 2022;43:638\u201345.","journal-title":"Nucl Med Commun"},{"key":"3797_CR13","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1097\/RLU.0000000000003537","volume":"46","author":"O Orozco-G\u00e1lvez","year":"2021","unstructured":"Orozco-G\u00e1lvez O, Fern\u00e1ndez-Codina A, Sim\u00f3-Perdigo M, Pinal-Fern\u00e1ndez I, Mart\u00ednez-Valle F. Response to treatment in IgG4-related disease assessed by quantitative PET\/CT scan. Clin Nucl Med. 2021;46:e307\u201311.","journal-title":"Clin Nucl Med"},{"key":"3797_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13550-020-00743-w","volume":"10","author":"K Mitamura","year":"2020","unstructured":"Mitamura K, Arai-Okuda H, Yamamoto Y, Norikane T, Takami Y, Fujimoto K, et al. Disease activity and response to therapy monitored by [18F] FDG PET\/CT using volume-based indices in IgG4-related disease. EJNMMI Res. 2020;10:153.","journal-title":"EJNMMI Res"},{"key":"3797_CR15","first-page":"424","volume":"46","author":"CJ Jaskowiak","year":"2005","unstructured":"Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP. Influence of reconstruction iterations on 18F-FDG PET\/CT standardized uptake values. J Nucl Med. 2005;46:424\u20138.","journal-title":"J Nucl Med"},{"key":"3797_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nucmedbio.2012.10.014","volume":"40","author":"KA B\u00fcsing","year":"2013","unstructured":"B\u00fcsing KA, Sch\u00f6nberg SO, Brade J, Wasser K. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET\/CT. Nucl Med Biol. 2013;40:206\u201313.","journal-title":"Nucl Med Biol"},{"key":"3797_CR17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s002590100566","volume":"28","author":"D Visvikis","year":"2001","unstructured":"Visvikis D, Cheze-Lerest C, Costa DC, Bomanji J, Gacinovic S, Ell PJ. Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F] FDG PET. Eur J Nucl Med. 2001;28:1326\u201335.","journal-title":"Eur J Nucl Med"},{"key":"3797_CR18","first-page":"559","volume":"45","author":"H Sch\u00f6der","year":"2004","unstructured":"Sch\u00f6der H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med. 2004;45:559\u201366.","journal-title":"J Nucl Med"},{"issue":"Suppl 2","key":"3797_CR19","doi-asserted-by":"publisher","first-page":"93S","DOI":"10.2967\/jnumed.110.085662","volume":"52","author":"R Boellaard","year":"2011","unstructured":"Boellaard R. Need for standardization of 18F-FDG PET\/CT for treatment response assessments. J Nucl Med. 2011;52(Suppl 2):93S\u2013100S.","journal-title":"J Nucl Med"},{"key":"3797_CR20","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2967\/jnumed.108.054239","volume":"49","author":"C Nahmias","year":"2008","unstructured":"Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008;49:1804\u20138.","journal-title":"J Nucl Med"},{"key":"3797_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/RLU.0000000000003774","volume":"46","author":"KP Horn","year":"2021","unstructured":"Horn KP, Thomas HMT, Vesselle HJ, Kinahan PE, Miyaoka RS, Rengan R, et al. Reliability of quantitative 18F-FDG PET\/CT imaging biomarkers for classifying early response to chemoradiotherapy in patients with locally advanced non\u2013small cell lung cancer. Clin Nucl Med. 2021;46:861\u201371.","journal-title":"Clin Nucl Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03797-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03797-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03797-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T13:05:39Z","timestamp":1708607139000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03797-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3797"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03797-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for the publication of this report and any accompanying images. Patient data were anonymized to ensure privacy and confidentiality, and case report publication was exempted from ethical review and approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}},{"value":"Informed written consent was obtained from the patient for publication of this report and any accompanying images. Patient data were anonymized to ensure privacy and confidentiality, and the publication of the case report was exempt from ethical review and approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}